Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-07-22 Purchase |
2024-07-24 4:27 pm |
Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
8,333,333 | $12 | $99,999,996 | 1,288,519 (Indirect) |
View |
| 2024-07-22 Purchase |
2024-07-24 4:15 pm |
Artiva Biotherapeutics Inc. | ARTV | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH Schwab Andrew J. 10% Owner |
833,333 | $12 | $9,999,996 | 1,643,741 (Indirect) |
View |
| 2024-07-22 Purchase |
2024-07-22 8:26 pm |
Artiva Biotherapeutics Inc. | ARTV | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S 10% Owner |
416,666 | $12 | $4,999,992 | 2,398,324 (Direct) |
View |
| 2024-07-22 Purchase |
2024-07-22 8:25 pm |
Artiva Biotherapeutics Inc. | ARTV | GC Corp. GC Cell Corp 10% Owner |
2,083,332 | $12 | $24,999,984 | 5,117,845 (Indirect Direct) |
View |
| 2024-07-22 Purchase |
2024-07-22 8:22 pm |
Artiva Biotherapeutics Inc. | ARTV | Huh Yong-Jun Director |
2,083,332 | $12 | $24,999,984 | 1,810,945 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-05 Option Award |
2025-03-07 4:35 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | Aslan Fred President and CEO |
200,000 | $0 | 416,665 (Direct) |
View |
| 2025-02-26 Option Award |
2025-02-28 5:15 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | Raymon Heather SVP, Research and Development |
33,350 | $0 | 43,350 (Direct) |
View |
| 2025-02-26 Option Award |
2025-02-28 5:15 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | Graef Thorsten Chief Medical Officer |
60,000 | $0 | 80,000 (Direct) |
View |
| 2025-02-26 Option Award |
2025-02-28 5:15 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | Horan Christopher Chief Tech Operations Officer |
60,000 | $0 | 85,000 (Direct) |
View |
| 2025-02-26 Option Award |
2025-02-28 5:15 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | Krishnamohan Neha Chief Financial Officer |
60,000 | $0 | 110,000 (Direct) |
View |
| 2025-02-26 Option Award |
2025-02-28 5:15 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | Bush Jennifer COO, CLO, Secy, Compliance Off |
86,650 | $0 | 159,449 (Direct) |
View |
| 2025-01-28 Option Award |
2025-01-29 4:33 pm |
N/A 2035-01-27 |
Artiva Biotherapeutics Inc. | ARTV | Baker Daniel G. Director |
27,500 | $0 | 27,500 (Direct) |
View |
| 2024-10-21 Option Award |
2024-10-22 8:18 pm |
N/A 2034-10-20 |
Artiva Biotherapeutics Inc. | ARTV | MOORE ALISON Director |
27,500 | $0 | 27,500 (Direct) |
View |
| 2024-09-12 Option Award |
2024-09-13 4:15 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | Raymon Heather SVP, Research and Development |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-09-12 Option Award |
2024-09-13 4:15 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | Graef Thorsten Chief Medical Officer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-09-12 Option Award |
2024-09-13 4:15 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | Horan Christopher Chief Tech Operations Officer |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-09-12 Option Award |
2024-09-13 4:15 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | Krishnamohan Neha Chief Financial Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-09-12 Option Award |
2024-09-13 4:15 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | Bush Jennifer COO, CLO, Secy, Compliance Off |
50,000 | $0 | 72,799 (Direct) |
View |
| 2024-07-22 Conversion |
2024-07-24 4:27 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
2,048,244 | $0 | 1,288,519 (Indirect) |
View |
| 2024-07-22 Other |
2024-07-24 4:27 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
461,687 | $10.2 | 1,288,519 (Indirect) |
View |
| 2024-07-22 Conversion |
2024-07-24 4:15 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH Schwab Andrew J. 10% Owner |
2,116,568 | $0 | 1,643,741 (Indirect) |
View |
| 2024-07-22 Other |
2024-07-24 4:15 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH Schwab Andrew J. 10% Owner |
461,687 | $10.2 | 1,643,741 (Indirect) |
View |
| 2024-07-22 Conversion |
2024-07-22 8:28 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner |
145,089 | $0 | 243,127 (Direct) |
View |
| 2024-07-22 Other |
2024-07-22 8:28 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner |
49,019 | $10.2 | 243,127 (Direct) |
View |
| 2024-07-22 Conversion |
2024-07-22 8:26 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S 10% Owner |
1,058,284 | $0 | 2,398,324 (Direct) |
View |
| 2024-07-22 Other |
2024-07-22 8:26 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S 10% Owner |
461,687 | $0 | 2,398,324 (Direct) |
View |
| 2024-07-22 Conversion |
2024-07-22 8:25 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | GC Corp. GC Cell Corp 10% Owner |
1,352,252 | $0 | 5,117,845 (Direct) |
View |
| 2024-07-22 Other |
2024-07-22 8:25 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | GC Corp. GC Cell Corp 10% Owner |
550,433 | $10.2 | 5,117,845 (Direct) |
View |
| 2024-07-22 Conversion |
2024-07-22 8:22 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | Huh Yong-Jun Director |
1,352,252 | $0 | 1,810,945 (Indirect) |
View |
| 2024-07-22 Other |
2024-07-22 8:22 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | Huh Yong-Jun Director |
550,433 | $10.2 | 1,810,945 (Indirect) |
View |
| 2024-07-18 Option Award |
2024-07-22 8:18 pm |
N/A 2034-07-17 |
Artiva Biotherapeutics Inc. | ARTV | Aslan Fred President and CEO |
572,716 | $0 | 572,716 (Direct) |
View |
Ownership |
2024-07-18 8:14 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S 10% Owner |
0 | $0 | 1,058,284 (Direct) |
View |
Ownership |
2024-07-18 8:08 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
0 | $0 | 1,058,282 (Indirect) |
View |
Ownership |
2024-07-18 8:06 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | 5AM Partners VI LLC 5AM Ventures VI L.P. PARMAR KUSH Schwab Andrew J. 10% Owner |
0 | $0 | 1,058,284 (Indirect) |
View |
Ownership |
2024-07-18 8:06 pm |
2024-05-01 2034-01-23 |
Artiva Biotherapeutics Inc. | ARTV | Miralles Gines Diego Director |
0 | $0 | 25,990 (Direct) |
View |
Ownership |
2024-07-18 8:06 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner |
0 | $0 | 145,089 (Direct) |
View |
Ownership |
2024-07-18 8:05 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | GC Corp. GC Cell Corp 10% Owner |
0 | $0 | 1,933,647 (Direct) |
View |
Ownership |
2024-07-18 8:04 pm |
N/A 2033-04-02 |
Artiva Biotherapeutics Inc. | ARTV | HOUGEN ELIZABETH L Director |
0 | $0 | 17,098 (Direct) |
View |
Ownership |
2024-07-18 8:02 pm |
N/A 2030-11-02 |
Artiva Biotherapeutics Inc. | ARTV | Raymon Heather SVP, Research and Development |
0 | $0 | 67,255 (Direct) |
View |
Ownership |
2024-07-18 8:02 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | Huh Yong-Jun Director |
0 | $0 | 1,933,647 (Indirect) |
View |
Ownership |
2024-07-18 8:02 pm |
N/A 2033-04-02 |
Artiva Biotherapeutics Inc. | ARTV | Bessen Laura Director |
0 | $0 | 17,098 (Direct) |
View |
Ownership |
2024-07-18 8:01 pm |
N/A 2033-04-02 |
Artiva Biotherapeutics Inc. | ARTV | Graef Thorsten Chief Medical Officer |
0 | $0 | 110,578 (Direct) |
View |
Ownership |
2024-07-18 8:01 pm |
N/A 2034-05-01 |
Artiva Biotherapeutics Inc. | ARTV | Krishnamohan Neha Chief Financial Officer |
0 | $0 | 102,599 (Direct) |
View |
Ownership |
2024-07-18 8:01 pm |
N/A 2033-04-02 |
Artiva Biotherapeutics Inc. | ARTV | Horan Christopher Chief Tech Operations Officer |
0 | $0 | 107,157 (Direct) |
View |
Ownership |
2024-07-18 8:00 pm |
N/A N/A |
Artiva Biotherapeutics Inc. | ARTV | Bush Jennifer COO, CLO, Secy, Compliance Off |
0 | $0 | 107,678 (Direct) |
View |
Ownership |
2024-07-18 8:00 pm |
N/A 2033-04-02 |
Artiva Biotherapeutics Inc. | ARTV | Aslan Fred President and CEO |
0 | $0 | 549,808 (Direct) |
View |